Primary PPDLSCs were obtained from premolar and/or third molar extractions of 8 donors (38.9 ± 7.9 years old) for therapeutic reasons who were diagnosed with chronic periodontitis. Primary HPDLSCs were isolated from 10 orthodontic patients (37.9 ± 7.2 years old) who underwent routine premolar and/or third molar extractions. All samples were collected at the Department of Orthodontics, School of Stomatology, the Fourth Military Medical University. Periodontitis patients were collected according to the following criteria made by the same periodontal specialist: bleeding on probe; periodontal pocket < 6 mm with 3-4 mm attachment loss; and/or alveolar bone absorption up to 1/3-1/2 root length horizontally on X-ray images. None of these subjects were selected with any clinical evidence of systemic disease or an acute infection in the past 6 months, and no one had a smoking history, drug utilization, or ever received maxillofacial radiotherapy and chemotherapy [6, 15]. All subjects provided written informed consent in accordance with the Declaration of Helsinki, and the study reached a consensus with the Ethics Committee of the Fourth Military Medical University (Approval Number: 2017(026)). The primary cells were cultured in α-MEM (Gibco BRL, Gaithersburg, MD, USA) with 10% fetal bovine serum (FBS) (Invitrogen, Carlsbad, CA, USA) in a humidified environment at 37°C with 5% CO2 [14]. Cell colonies were established by the limiting dilution technique [16].
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.